- Home
- Labeler Index
- Alexion Pharmaceuticals Inc.
- 25682-022
- NDC Crossover: 25682-022 Ultomiris
NDC Crossover 25682-022 Ultomiris
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Ravulizumab
Explore similar products and medications to NDC 25682-022 Ultomiris a human prescription drug with other products crossover matching the same product name (Ultomiris) or generic name (Ravulizumab), and the same administration route (intravenous) or dosage form (solution, concentrate). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
25682-025 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | Human Prescription Drug |
25682-028 | Ultomiris | Ravulizumab | Solution, Concentrate | Intravenous | Alexion Pharmaceuticals Inc. | Human Prescription Drug |